A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening

Microalbuminuria screening is cost-effective for patients with diabetes or hypertension, but is not cost-effective for patients with neither diabetes nor hypertension unless screening is conducted at longer intervals or as part of existing physician visits.